Cullinan Associates Inc Astrazeneca PLC Transaction History
Cullinan Associates Inc
- $1.5 Billion
- Q2 2025
A detailed history of Cullinan Associates Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Cullinan Associates Inc holds 8,026 shares of AZN stock, worth $667,923. This represents 0.04% of its overall portfolio holdings.
Number of Shares
8,026
Previous 13,026
38.38%
Holding current value
$667,923
Previous $957,000
41.48%
% of portfolio
0.04%
Previous 0.07%
Shares
12 transactions
Others Institutions Holding AZN
# of Institutions
1,439Shares Held
498MCall Options Held
7.22MPut Options Held
2.57M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.32 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.43 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.86 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.61 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.59 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $258B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...